Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Cells
|
October 23, 2021
Restoring the Cell Cycle and Proliferation Competence in Terminally Differentiated Skeletal Muscle Myotubes
Deborah Pajalunga, Marco Crescenzi
Cell Cycle (Georgetown, Tex.)
|
December 22, 2004
Regulation of cyclin E protein levels through E2F-mediated inhibition of degradation
Deborah Pajalunga, Marco Crescenzi
Cell Cycle (Georgetown, Tex.)
|
June 22, 2007
Non-proliferation as an active state: conceptual and practical implications
Deborah Pajalunga, Alessia Mazzola, Eleonora Puggioni, et al.
Plos One
|
July 21, 2010
DNA replication is intrinsically hindered in terminally differentiated myotubes
Deborah Pajalunga, Eleonora M R Puggioni, Alessia Mazzola, et al.
The Journal of Cell Biology
|
March 14, 2007
Critical requirement for cell cycle inhibitors in sustaining nonproliferative states
Deborah Pajalunga, Alessia Mazzola, Anna Maria Salzano, et al.
The Journal of Cell Biology
|
November 3, 2004
A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells
Grazia Camarda, Francesca Siepi, Deborah Pajalunga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 18, 2007
Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury
Laura Narciso, Paola Fortini, Deborah Pajalunga, et al.
The Journal of Clinical Investigation
|
October 15, 2005
A cancer-specific transcriptional signature in human neoplasia
Francesco Nicassio, Fabrizio Bianchi, Maria Capra, et al.
Cell Death and Differentiation
|
February 11, 2017
A defective dNTP pool hinders DNA replication in cell cycle-reactivated terminally differentiated muscle cells
Deborah Pajalunga, Elisa Franzolin, Martina Stevanoni, et al.
Cancer Cell
|
August 18, 2012
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling
Fabiola Cecchi, Deborah Pajalunga, C Andrew Fowler, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Cells
|
October 23, 2021
Restoring the Cell Cycle and Proliferation Competence in Terminally Differentiated Skeletal Muscle Myotubes
Deborah Pajalunga, Marco Crescenzi
Cell Cycle (Georgetown, Tex.)
|
December 22, 2004
Regulation of cyclin E protein levels through E2F-mediated inhibition of degradation
Deborah Pajalunga, Marco Crescenzi
Cell Cycle (Georgetown, Tex.)
|
June 22, 2007
Non-proliferation as an active state: conceptual and practical implications
Deborah Pajalunga, Alessia Mazzola, Eleonora Puggioni, et al.
Plos One
|
July 21, 2010
DNA replication is intrinsically hindered in terminally differentiated myotubes
Deborah Pajalunga, Eleonora M R Puggioni, Alessia Mazzola, et al.
The Journal of Cell Biology
|
March 14, 2007
Critical requirement for cell cycle inhibitors in sustaining nonproliferative states
Deborah Pajalunga, Alessia Mazzola, Anna Maria Salzano, et al.
The Journal of Cell Biology
|
November 3, 2004
A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells
Grazia Camarda, Francesca Siepi, Deborah Pajalunga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 18, 2007
Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury
Laura Narciso, Paola Fortini, Deborah Pajalunga, et al.
The Journal of Clinical Investigation
|
October 15, 2005
A cancer-specific transcriptional signature in human neoplasia
Francesco Nicassio, Fabrizio Bianchi, Maria Capra, et al.
Cell Death and Differentiation
|
February 11, 2017
A defective dNTP pool hinders DNA replication in cell cycle-reactivated terminally differentiated muscle cells
Deborah Pajalunga, Elisa Franzolin, Martina Stevanoni, et al.
Cancer Cell
|
August 18, 2012
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling
Fabiola Cecchi, Deborah Pajalunga, C Andrew Fowler, et al.
Page
of 2